• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催产素用于功能失调性分娩的加强治疗。IV. 催产素的药代动力学。

Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacokinetics.

作者信息

Seitchik J, Amico J, Robinson A G, Castillo M

出版信息

Am J Obstet Gynecol. 1984 Oct 1;150(3):225-8. doi: 10.1016/s0002-9378(84)90355-7.

DOI:10.1016/s0002-9378(84)90355-7
PMID:6486188
Abstract

Plasma oxytocin levels ([OT[p) were measured every 20 minutes during infusions of oxytocin. The initial dose of 1 mU/min was incremented, if necessary, by 1 mU/min at 40-minute intervals until sufficient contractility was obtained to effect cervical dilatation. The results demonstrated: the [OT]p rises linearly with each dose for the first 40 minutes of the infusion; there is no difference between the 40- and 60-minute sample values, suggesting that the peak [OT]p of each dose is achieved in 40 minutes; the increment in [OT]p required to produce effective contractility varies widely from 0.58 to 5.09 microU/ml; the plasma clearance rate varied from 11.2 to 32.5 ml/kg/min. Approximately 40 minutes is required for any particular dose of oxytocin to reach a "steady-state" [OT]p and the maximal uterine contractile response. The design of regimens for the augmentation or induction of labor should be based on this knowledge.

摘要

在输注催产素期间,每隔20分钟测量一次血浆催产素水平([OT]p)。初始剂量为1 mU/分钟,如有必要,每隔40分钟以1 mU/分钟的幅度递增,直至获得足够的宫缩力以实现宫颈扩张。结果表明:在输注的前40分钟内,[OT]p随每次剂量呈线性上升;40分钟和60分钟的样本值之间没有差异,这表明每个剂量的[OT]p峰值在40分钟内达到;产生有效宫缩力所需的[OT]p增量差异很大,从0.58到5.09微单位/毫升不等;血浆清除率在11.2至32.5毫升/千克/分钟之间变化。任何特定剂量的催产素达到“稳态”[OT]p和最大子宫收缩反应大约需要40分钟。引产或催产方案的设计应基于这一认识。

相似文献

1
Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacokinetics.催产素用于功能失调性分娩的加强治疗。IV. 催产素的药代动力学。
Am J Obstet Gynecol. 1984 Oct 1;150(3):225-8. doi: 10.1016/s0002-9378(84)90355-7.
2
Oxytocin augmentation of dysfunctional labor. V. An alternative oxytocin regimen.缩宫素用于产程异常的加强。V. 一种替代缩宫素方案。
Am J Obstet Gynecol. 1985 Mar 15;151(6):757-61. doi: 10.1016/0002-9378(85)90514-9.
3
Novel approach to oxytocin induction-augmentation of labor. Application of oxytocin physiology during pregnancy.催产素引产 - 增强宫缩的新方法。孕期催产素生理学的应用。
Adv Exp Med Biol. 1995;395:585-94.
4
Oxytocin pharmacodynamics: effect of long infusions on uterine activity.催产素药效学:长时间输注对子宫活动的影响。
Gynecol Obstet Invest. 1991;31(1):17-22. doi: 10.1159/000293094.
5
Studies of oxytocin in plasma of women during hypocontractile labor.低收缩性分娩期间女性血浆中催产素的研究。
J Clin Endocrinol Metab. 1984 Feb;58(2):274-9. doi: 10.1210/jcem-58-2-274.
6
Oxytocin augmentation of dysfunctional labor. III. Multiparous patients.缩宫素用于增强宫缩乏力性产程。III. 经产妇
Am J Obstet Gynecol. 1983 Apr 1;145(7):777-80. doi: 10.1016/0002-9378(83)90677-4.
7
Secretion of oxytocin in pregnant and parturient cows: corpus luteum may contribute to plasma oxytocin at term.妊娠和分娩期母牛的催产素分泌:黄体可能在足月时对血浆催产素有所贡献。
Biol Reprod. 2001 Oct;65(4):1135-41. doi: 10.1095/biolreprod65.4.1135.
8
Oxytocin augmentation of labor: a comparison of 15- and 30-minute dose increment intervals.缩宫素引产:15分钟和30分钟剂量增加间隔的比较
Obstet Gynecol. 1988 Feb;71(2):147-9.
9
The pharmacokinetics of oxytocin as they apply to labor induction.缩宫素用于引产时的药代动力学。
Am J Obstet Gynecol. 1996 May;174(5):1590-3. doi: 10.1016/s0002-9378(96)70611-7.
10
Evolving concepts of oxytocin for induction of labor.缩宫素用于引产的概念演变
Am J Perinatol. 1989 Apr;6(2):167-72. doi: 10.1055/s-2007-999569.

引用本文的文献

1
Propranolol and Oxytocin-Induced Contractility in Gravid Human Myometrium: An Ex Vivo Laboratory Study.普萘洛尔和催产素对妊娠子宫肌层收缩性的影响:一项体外实验室研究
BJOG. 2025 Aug;132(9):1228-1237. doi: 10.1111/1471-0528.18146. Epub 2025 Mar 24.
2
Stimulation Therapy to Induce Mothers: Protocol for a Multicenter Randomized Controlled Trial.诱导母亲的刺激疗法:一项多中心随机对照试验方案。
JMIR Res Protoc. 2024 Aug 29;13:e63463. doi: 10.2196/63463.
3
Maternal and newborn plasma oxytocin levels in response to maternal synthetic oxytocin administration during labour, birth and postpartum - a systematic review with implications for the function of the oxytocinergic system.
产妇分娩、生产和产后接受合成催产素治疗时母血和新生儿血中催产素水平变化:一项系统综述——对催产素能系统功能的启示
BMC Pregnancy Childbirth. 2023 Mar 2;23(1):137. doi: 10.1186/s12884-022-05221-w.
4
Review of Evidence-Based Methods for Successful Labor Induction.循证方法在成功引产中的应用综述。
J Midwifery Womens Health. 2021 Jul;66(4):459-469. doi: 10.1111/jmwh.13238. Epub 2021 May 13.
5
Inter-institutional variations in oxytocin augmentation during labour in German university hospitals: a national survey.德国大学医院分娩时催产素强化使用的机构间差异:一项全国性调查。
BMC Pregnancy Childbirth. 2019 Jul 9;19(1):238. doi: 10.1186/s12884-019-2348-x.
6
The Oxytocin Product Correlates with Total Oxytocin Received during Labor: A Research Methods Study.缩宫素产品与分娩期间接受的总缩宫素相关:一项研究方法研究。
Am J Perinatol. 2018 Jan;35(1):78-83. doi: 10.1055/s-0037-1606119. Epub 2017 Aug 14.
7
The association of single-nucleotide polymorphisms in the oxytocin receptor and G protein-coupled receptor kinase 6 (GRK6) genes with oxytocin dosing requirements and labor outcomes.催产素受体和G蛋白偶联受体激酶6(GRK6)基因中的单核苷酸多态性与催产素给药需求及分娩结局的关联。
Am J Obstet Gynecol. 2017 Sep;217(3):367.e1-367.e9. doi: 10.1016/j.ajog.2017.05.023. Epub 2017 May 17.
8
Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.在非医疗机构分娩环境中使用缩宫素预防产后出血
Cochrane Database Syst Rev. 2016 Apr 14;4(4):CD011491. doi: 10.1002/14651858.CD011491.pub2.
9
Oxytocin exposure during labor among women with postpartum hemorrhage secondary to uterine atony.产妇宫缩乏力性产后出血患者分娩时使用缩宫素。
Am J Obstet Gynecol. 2011 Jan;204(1):56.e1-6. doi: 10.1016/j.ajog.2010.08.023. Epub 2010 Nov 3.
10
Chemotherapeutic induction of labour. A rational approach.化疗引产。一种合理的方法。
Drugs. 1997 Jul;54(1):61-8. doi: 10.2165/00003495-199754010-00005.